BillionToOne, Inc.
$86.97
▼
-4.34%
2026-04-21 05:42:01
www.billiontoone.com
NMS: BLLN
Explore BillionToOne, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.65 B
Current Price
$86.97
52W High / Low
$138.7 / $61.96
Stock P/E
489.81
Book Value
$10.48
Dividend Yield
—
ROCE
2.74%
ROE
2.3%
Face Value
—
EPS
$0.14
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
713
Beta
—
Debt / Equity
22.68
Current Ratio
11.69
Quick Ratio
11.32
Forward P/E
90.65
Price / Sales
12.22
Enterprise Value
$3.34 B
EV / EBITDA
145.73
EV / Revenue
10.95
Rating
Buy
Target Price
$116.71
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Capital efficiency is modest.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Advanced Biomed Inc. | $5 | 1.49 | $6.55 M | — | — | 80.18% | $48.8 / $3.61 | $8.76 |
| 2. | Personalis, Inc. | $6.34 | — | $663.37 M | — | -29.9% | -35.02% | $11.5 / $3.09 | $2.55 |
| 3. | Qiagen N.V. | NOT FOUND | — | — | 0.64% | 9.02% | 11.57% | $57.81 / $38.8 | $18.33 |
| 4. | GRAIL, Inc. | $51.2 | — | $2.1 B | — | -18.79% | -16.07% | $118.84 / $25.56 | $63.92 |
| 5. | FONAR Corporation | $18.8 | 15.61 | $117.93 M | — | 5.81% | 6.01% | $18.86 / $12 | $27.01 |
| 6. | Revvity, Inc. | $93.89 | 28.42 | $10.54 B | 0.3% | 3.29% | 3.22% | $118.3 / $81.36 | $64.57 |
| 7. | OPKO Health, Inc. | $1.22 | — | $926.06 M | — | -12.27% | -17.14% | $1.6 / $1.09 | $1.67 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|
| Sales | 96.05 M | 83.52 M | 45.08 M | 38.42 M |
| Operating Profit | 10.33 M | 9.63 M | -11.69 M | -12.63 M |
| Net Profit | 5.98 M | 5.71 M | -11.48 M | -14.9 M |
| EPS in Rs | 0.14 | 0.14 | -0.28 | -0.36 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Sales | 305.11 M | — | — |
| Operating Profit | 16.02 M | — | — |
| Net Profit | 7.45 M | — | — |
| EPS in Rs | 0.18 | -1.05 | -2.1 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Total Assets | 632.65 M | — | — |
| Total Liabilities | 152.55 M | — | — |
| Equity | 480.11 M | — | — |
| Current Assets | 560.56 M | — | — |
| Current Liabilities | 47.96 M | — | — |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Operating CF | 24.59 M | — | — |
| Investing CF | -8.92 M | — | — |
| Financing CF | 288.82 M | — | — |
| Free CF | 15.67 M | — | — |
| Capex | -8.92 M | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue Growth % | — | — | — |
| Earnings Growth % | — | — | — |
| Profit Margin % | 2.44% | — | — |
| Operating Margin % | 5.25% | — | — |
| Gross Margin % | 68.32% | — | — |
| EBITDA Margin % | 6.48% | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.